Citations

Mayo Clinic

Showing 10 of 108147 citations.

Reframing the Spectrum of Benign Prostatic Hyperplasia Management: Impact and Implications of the 2026 AUA Guideline
Wymer, Kevin M., Koo, Kevin , Wymer, Kevin

Journal of Urology | June 12, 2026 | Volume: 216 | Issue: 4 | Pages: 494-496

10.1097/ju.0000000000005162 | PMID 42284178 Get It

Aging slows maximum shortening velocity and reduces peak power output of rat diaphragm muscle
Hernandez-Vizcarrondo, Genesis, Fogarty, Matthew J. , Abdulkader, Humzah , Sieck, Lucy, Mantilla, Carlos B. , Sieck, Gary C. , Hernandez-Vizcarrondo, Genesis A , Sieck, Lucy C, Sieck, Gary , Mantilla, Carlos B , Fogarty, Matthew J

Journal of Applied Physiology | June 12, 2026 | Volume: 141 | Issue: 1 | Pages: 194-204

10.1152/japplphysiol.00148.2026 | PMID 42284111 Get It

Aging selectively impacts the function of type IIx/IIb fibers in the diaphragm muscle. We show that sarcopenia reduces maximum specific force, maximum shortening velocity, and peak power output, whereas endurance during repetitive contractions is preserved. These findings explain why higher force airway clearance behaviors decline with age, whereas fatigue-resistant breathing behavior remains resilient.
Study of Metformin and GLP-1 Receptor Agonist Use in Hidradenitis Suppurativa Using the NIH All of Us Research Program
Shrestha, Raslina , Nguyen, Giang H., McCoy, Rozalina G. , Nguyen, Giang Huong , McCoy, Rozalina Grubina , Nguyen, Giang H

Diabetes Care | June 12, 2026 | Volume: 49 | Issue: 8 | Pages: e138-e139

10.2337/dc26-0165 | PMID 42283704 Get It

Prior Calf Strain as a Risk Factor for Achilles Tendon Rupture in National Basketball Association Players: A Retrospective Analysis
Elsabbagh, Zaid , Le, Ysa, Bcharah, George , Ryu, David , Hsu, Nigel , Thompson, John Michael, Aiyer, Amiethab, Le, Ysa , Ryu, David , Badin, Daniel , Thompson, John Michael, Aiyer, Amiethab A.

Orthopaedic Journal of Sports Medicine | June 12, 2026 | Volume: 14 | Issue: 6 | Pages: No page available

10.1177/23259671261449170 | PMID 42293040 Get It

Background: Achilles tendon ruptures are among the most debilitating injuries in professional basketball, often leading to prolonged absence and long-term performance decline. While calf strains are common among National Basketball Association (NBA) athletes, their role as a precursor to Achilles rupture remains poorly understood. Hypothesis: A previous calf strain would be associated with increased odds of Achilles tendon rupture in NBA players and that affected players would experience significant post-injury performance declines. Study Design: Case-cohort study; Level of evidence, 3. Methods: Publicly available data on NBA players from 1958 to 2024 were analyzed, with the data search conducted in June 2025. Players with Achilles ruptures (n = 60) were compared with players with calf strains who did not sustain a rupture (n = 258). Logistic regression adjusted for age, body mass index, position, starter status, and workload. Pre- and postinjury performance was evaluated over 2 seasons using paired t tests. Descriptive analyses characterized injury laterality, game context, quarter, shoe type, and draft position. Video review assessed injury mechanisms. Results: Previous calf strain was associated with increased odds of Achilles rupture (odds ratio, 2.49; 95% CI, 1.16-5.22; P = .02). Among those with both injuries, 85.7% occurred on the same side, with a mean interval of 1.9 years. Of all players, a total of 75% returned to play. Postinjury declines were observed in player efficiency rating (−2.46), win shares (−3.23), games played (−260.3), and minutes per game (−5.19) (all P < .001). Return was more likely in younger players and those on multiyear contracts. Video analysis revealed a consistent “false step” mechanism in 95% of cases with footage. Most Achilles tendon ruptures occurred during in-game activity, while shoe type was evaluated descriptively and was not associated with player position or preinjury workload. Conclusion: Our study showed that previous calf strain is associated with an increased risk of Achilles tendon rupture in NBA players and may serve as a clinically identifiable risk marker. Rupture leads to substantial and sustained performance decline, even among those who return. Targeted rehabilitation and movement retraining may help mitigate progression to rupture in high-risk athletes.
Preventive Care in Inflammatory Bowel Disease
Caldera, Freddy , Fa, Farraye, Caldera, Freddy

American Journal of Gastroenterology | June 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.14309/ajg.0000000000004070 | PMID 42283515 Get It

The Evolving Role of Clinical Anatomy: From Definition to Contribution
IWANAGA, Joe, Spinner, Robert J. , Bubb, Kathleen , D’Antoni, Anthony V. , Tabira, Yoko , Loukas, Marios , Tubbs, R. Shane, Khalil, Mohammed K , Loukas, Marios , Tabira, Yoko , Iwanaga, Joe , Khalil, Mohammed K.

Clinical Anatomy | June 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ca.70166 | PMID 42283378 Get It

ABSTRACT The term “clinical anatomy” is widely used in education and research, yet its conceptual boundaries continue to be interpreted in various ways. Prior consensus‐based efforts have emphasized integration, collaboration, and clinical relevance as central features of the field and have provided an important foundation for interdisciplinary engagement. At the same time, ongoing changes in academic structure, medical education, and interdisciplinary biomedical science raise important questions regarding how clinical anatomy can sustain its scientific identity and long‐term relevance. Building upon prior discussions, this article argues that the continued maturation of clinical anatomy depends on the integration of conceptual frameworks with the sustained production of rigorous, reproducible, and clinically meaningful scholarly contributions. Historical and contemporary examples alike demonstrate that the influence of clinical anatomy has been shaped through contributions that directly advanced clinical science and practice. Accordingly, continued emphasis on methodological rigor, reproducibility, clinically meaningful contribution, and educational accountability may be essential to the field's future development and relevance.
Glomerulopatia C3: avanços recentes e atualizações no manejo
Holanda, Maria Izabel de , Sethi, Sanjeev , Palma, Lilian Monteiro P

Brazilian Journal of Nephrology | June 12, 2026 | Volume: 48 | Issue: 2 | Pages: No page available

10.1590/2175-8239-jbn-2025-0306pt Get It

Resumo A glomerulopatia C3 (C3G) é uma entidade clinicopatológica caracterizada por inflamação glomerular com dominância de C3 à imunofluorescência. A microscopia eletrônica é utilizada para determinar a localização e o tipo de depósitos, o que permite subdividir a C3G em glomerulonefrite C3 (GNC3) e doença de depósitos densos (DDD) com base em achados ultraestruturais. Ambas as entidades são progressivas, com cerca de 60% dos pacientes evoluindo para doença renal terminal (DRT) em 10 anos. A recorrência após o transplante renal ocorre em até 60% dos casos de C3G. Novos conhecimentos sobre a fisiopatologia—diferentes padrões de lesão, escores histopatológicos, coloração para apolipoproteína E, desregulação da via alternativa do complemento, que inclui autoanticorpos e mutações em fatores reguladores do complemento, bem como análises proteômicas—permitiram uma melhor compreensão dos diferentes perfis fisiopatológicos e apresentações clínicas, possibilitando um tratamento individualizado. O papel da nefroproteção está bem estabelecido na C3G, assim como em outras doenças glomerulares. O tratamento não específico com corticosteroides e imunossupressores está associado a uma taxa de resposta variável. No entanto, mais recentemente, os resultados de ensaios clínicos com inibidores proximais da via alternativa do complemento demonstraram melhora significativa na proteinúria e atenuação da redução da taxa de filtração glomerular estimada (TFGe). Com base nos resultados desses ensaios com medicamentos que atuam especificamente nas vias do complemento a montante, incluindo a via alternativa, novas opções de tratamento tornaram-se disponíveis para pacientes com C3G.
C3 Glomerulopathy: recent advances and an update on management
Holanda, Maria Izabel de , Sethi, Sanjeev , Palma, Lilian Monteiro P , Barbosa, Maria Izabel Neves de Holanda , Sethi, Sanjeev

Brazilian Journal of Nephrology | June 12, 2026 | Volume: 48 | Issue: 2 | Pages: No page available

10.1590/2175-8239-jbn-2025-0306en | PMID 42284585 Get It

Abstract C3 glomerulopathy (C3G) is a clinicopathologic entity characterized by glomerular inflammation with dominant staining for C3 on immunofluorescence microscopy. Electron microscopy is used to determine the location and type of deposits, which further divides C3G into C3 glomerulonephritis (C3GN) and dense deposit disease (DDD) based on ultrastructural findings. Both entities are progressive, with about 60% of patients progressing to end-stage kidney disease (ESKD) within 10 years. Recurrence after kidney transplantation occurs in up to 60% of C3G cases. New knowledge about the pathophysiology—different patterns of injury, histopathological scoring, apolipoprotein E staining, dysregulation of the alternative complement pathway (including both autoantibodies to and mutations in complement regulatory factors), as well as proteomic analyses—has allowed a better understanding of different pathophysiological profiles and clinical presentations, enabling individualized treatment. The role of nephroprotection is well established in C3G, as it is for other glomerular diseases. Non-specific treatment with corticosteroids and immunosuppression is associated with a variable response rate. However, more recently, results from clinical trials with proximal complement inhibitors have shown significant improvement in proteinuria and attenuation of the decline in estimated glomerular filtration rate (eGFR). Based on the results of these trials involving drugs that specifically target the upstream complement pathways, including the alternative pathway, new treatment options have recently become available for patients with C3G.
Anal fistulas: do classification systems predict surgical outcomes?
Hora, José Américo Bacchi , Sobrado, Lucas Faraco , Sobrado-Junior, Carlos Walter , Horvat, Natally , Marques, Carlos Frederico Sparapan , Nahas, Sérgio Carlos , Sobrado, Carlos Walter , Ribeiro Junior, Ulysses , Nahas, Sérgio Carlos , Horvat, Natally , Ribeiro, Ulysses

ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) | June 12, 2026 | Volume: 38 | Issue: No issue available | Pages: No page available

10.1590/0102-67202025000058e1927 | PMID 42307399 Get It

ABSTRACT Background: Anal fistulas remain challenging in colorectal surgery, with recurrence and postoperative incontinence common despite advances in treatment. Multiple classification systems exist, but their predictive value for surgical and functional outcomes is unclear. Aims: The aim of this study was to compare Parks, American Society of Colon and Rectal Surgeons (ASCRS), and St. James’s University Hospital (SJUH) MRI-based classifications in predicting surgical outcomes, including continence preservation. Methods: Retrospective analysis of 89 patients undergoing definitive surgical treatment for anorectal fistulas at a single referral center (2012–2019). Exclusions included rectovaginal fistulas, Crohn’s disease, or prior pelvic radiotherapy. Fistulas were classified using Parks, ASCRS, and, when available, SJUH (n=49). Outcomes included the number of procedures, type of initial procedure, fistula closure, and closure without continence deterioration. Continence was assessed using the Cleveland Clinic Jorge-Wexner score. Results: Most fistulas were transsphincteric (Parks Type 2, 62%) and complex (ASCRS, 65%). Overall, 86.5% achieved fistula closure, and 73% achieved closure without continence deterioration. Parks and ASCRS were significantly associated with fistula closure with continence preservation (p=0.008 and 0.007, respectively) and type of initial procedure. Parks remained significant when considering closure alone (p=0.005), while ASCRS showed a borderline association (p=0.051). SJUH classification was associated only with procedure selection. Conclusions: Parks and ASCRS classifications were associated with fistula closure with continence preservation and type of initial procedure. Considering closure alone, only Parks remained significant. SJUH was limited to procedure selection. Overall, Parks and ASCRS guide surgical planning and prediction of functional outcomes, with Parks slightly more sensitive.
Operationalizing diffusion magnetic resonance imaging positivity for detection of vascular contributions to impairment and dementia
Hu, Mingzhao, Przybelski, Scott A. , Therneau, Terry M., Wiste, Heather J. , Mester, Carly , Kamykowski, Michael, Reid, Robert I., Machulda, Mary M., Knopman, David S., Petersen, Ronald C., Jack, Clifford R., Graff‐Radford, Jonathan, Vemuri, Prashanthi, Lundt, Emily S. , Mester, Carly T, Hu, Mingzhao, Therneau, Terry M. , Kamykowski, Michael G. , Reid, Robert I. , Machulda, Mary M. , Knopman, David S. , Petersen, Ronald C. , Jack, Clifford R. , Graff‐Radford, Jonathan , Vemuri, Prashanthi

Alzheimer's & Dementia | June 12, 2026 | Volume: 22 | Issue: 6 | Pages: No page available

10.1002/alz.71438 | PMID 42283327 Get It

Abstract INTRODUCTION White matter lesions on fluid‐attenuated inversion recovery magnetic resonance imaging (FLAIR‐MRI) reflect small vessel disease (SVD) and aid in identifying vascular contributions to impairment and dementia (VCID). Emerging diffusion MRI (dMRI) biomarkers are sensitive to early SVD but the lack of validated approaches for defining dMRI abnormality has limited their clinical utility. METHODS In 3934 participants (8749 observations) from a population‐based sample, we classified 9% as vascular cognitive impairment versus not (VCI+/VCI−) using abnormal FLAIR‐MRI and cognitive testing. We evaluated four distinct dMRI positivity criteria and assessed performance in an independent clinical sample. RESULTS The young referent criterion performed best and yielded an estimated prevalence of dMRI positivity aligned with pathology literature. About 40% of the population were dMRI positive, and these individuals had lower baseline cognition and faster longitudinal decline. Cutpoints were validated in an independent clinical sample. DISCUSSION The proposed dMRI abnormality framework can detect VCID and aid in identification of individuals at risk of VCI.